Principal Financial Group Inc Citius Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$0.6 - $0.9 $953 - $1,430	-1,589 Reduced 9.22%	15,649 $14,000
Q3 2023 Nov 02, 2023	BUY	$0.65 - $1.25 $2,370 - $4,558	3,647 Added 26.83%	17,238 $11,000
Q2 2023 Aug 07, 2023	BUY	$1.08 - $1.65 $14,678 - $22,425	13,591 New	13,591 $16,000
Q2 2022 Aug 10, 2022	SELL	$0.88 - $1.87 $14,553 - $30,926	-16,538 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$1.38 - $1.89 $1,286 - $1,761	-932 Reduced 5.33%	16,538 $30,000
Q4 2021 Feb 09, 2022	BUY	$1.51 - $2.2 $26,379 - $38,434	17,470 New	17,470 $27,000
Q3 2021 Nov 09, 2021	SELL	$1.74 - $2.6 $22,800 - $34,070	-13,104 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$1.51 - $4.23 $19,787 - $55,429	13,104 New	13,104 $45,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.